MarkNtel Advisors – Leading Market Research Company found Global Artificial Intelligence (AI) in Precision Medicine Market is expected to reach 27% CAGR Growth By 2030.
This report provides a comprehensive analysis of the Global Artificial Intelligence (AI) in Precision Medicine Market, with a focus on market size, segmentation, key players, geographical analysis, and growth in the coming years. The expert team of analysts invested considerable time and effort in collecting and analyzing the latest market data, producing a comprehensive and current report that provides valuable insights for decision-makers, including business owners and analysts.
Comprehensive Analysis of the Artificial Intelligence (AI) in Precision Medicine Market
Base Year: 2023 Forecast Years: 2024-2030 Historical Years: 2019-2022 ✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report. If you’re interested in the assumptions considered in this study, you can download the PDF brochure- – https://www.marknteladvisors.com/query/request-sample/global-artificial-intelligence-in-precision-medicine-market.htmlScope of the Artificial Intelligence (AI) in Precision Medicine Market Report:
The Global Artificial Intelligence (AI) in Precision Medicine Market size was valued at USD 1.7 billion in 2023 and is projected to reach USD 14.5 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 27% during the forecast period, i.e., 2024-30.Which prominent factor is expected to drive the Artificial Intelligence (AI) in Precision Medicine Market during 2024-30?
High Rates of Different Cancers to Impact the Market Positively – Throughout the world, there have been high rates of various cancers including breast & stomach. However, the currently available treatments like chemotherapy, radiation therapy, and others have not been very effective for every patient while some had negative consequences on the health of patients. There has been continuous research & development for therapies specifically tailored according to patient’s characteristics, and prove to be more effective compared to conventional treatments with minimal cost and no side effects. Subsequently, Artificial intelligence (AI) in precision medicine has accelerated the analysis of vast amounts of genomic or proteomic data rapidly, identifying disease targets, and rapid discovery and development of drugs thereby expanding the market size for AI in Precision Medicine. For instance,- The World Health Organization (WHO) reported about 20 million new cases of cancer globally in 2022 and also expects that the cases will eventually increase to around 32.6 million by 2045.
What are the different Segment Available in the Artificial Intelligence (AI) in Precision Medicine Market?
By Component- Hardware- Market Size & Forecast 2019-2030, USD Million
- Software- Market Size & Forecast 2019-2030, USD Million
- Services- Market Size & Forecast 2019-2030, USD Million
- Deep Learning- Market Size & Forecast 2019-2030, USD Million
- Machine Learning- Market Size & Forecast 2019-2030, USD Million
- Querying Method- Market Size & Forecast 2019-2030, USD Million
- Natural Language Processing- Market Size & Forecast 2019-2030, USD Million
- Context-Aware Processing- Market Size & Forecast 2019-2030, USD Million
- Oncology- Market Size & Forecast 2019-2030, USD Million
- Neurosciences- Market Size & Forecast 2019-2030, USD Million
- Cardiology- Market Size & Forecast 2019-2030, USD Million
- Hematological Diseases- Market Size & Forecast 2019-2030, USD Million
- Autoimmune Diseases- Market Size & Forecast 2019-2030, USD Million
- Others (Respiratory, Kidney Diseases, etc.)- Market Size & Forecast 2019-2030, USD Million
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific.
Leading Artificial Intelligence (AI) in Precision Medicine companies operating in the Market
- Tempus
- Intel Corporation
- Zephyr AI
- IBM
- NVIDIA Corporation
- Intuz
- Google LLC
- Persistent Systems
- Owkin, Inc.
- GE Healthcare
- Insilico Medicine
- Atomwise
- BioXcel Therapeutics
- Sanofi
- Others.